Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $28.16 and traded as high as $32.20. Acadia Healthcare shares last traded at $31.88, with a volume of 1,263,788 shares trading hands.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on ACHC. UBS Group upped their target price on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, September 9th. Barclays upped their price objective on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a report on Thursday, July 30th. Leerink Partners upped their target price on Acadia Healthcare from $30.00 to $33.00 and gave the stock a “market perform” rating in a research report on Wednesday, September 23rd. Finally, Raymond James Financial downgraded shares of Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 price objective for the company. in a report on Monday, September 28th. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, Acadia Healthcare currently has a consensus rating of “Hold” and a consensus target price of $30.69.
View Our Latest Analysis on ACHC
Acadia Healthcare Stock Performance
The company has a market capitalization of $2.93 billion, a P/E ratio of -2.53, a price-to-earnings-growth ratio of 10.27 and a beta of 0.63. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The firm has a 50 day moving average price of $28.88 and a two-hundred day moving average price of $28.19.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. During the same quarter last year, the business posted $0.83 earnings per share. The company’s revenue was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, research analysts expect that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current fiscal year.
Institutional Trading of Acadia Healthcare
Institutional investors and hedge funds have recently modified their holdings of the stock. Allworth Financial LP acquired a new stake in Acadia Healthcare in the second quarter worth $45,000. Global Retirement Partners LLC acquired a new position in Acadia Healthcare during the second quarter worth $68,000. Integrated Wealth Concepts LLC acquired a new stake in shares of Acadia Healthcare in the second quarter valued at about $79,000. Quantbot Technologies LP acquired a new position in Acadia Healthcare during the second quarter worth $88,000. Finally, Public Employees Retirement System of Ohio bought a new stake in Acadia Healthcare in the second quarter valued at approximately $144,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.
Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.
Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.
See Also
- Five stocks we like better than Acadia Healthcare
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
